The rate of decline of CD4 T-cells in people infected with HIV by Williams, Brian G. et al.
CD4 decline in HIV-positive people 
  1  
The rate of decline of CD4 T-cells in people infected with HIV 
Brian G. Williams,1 Eline L. Korenromp,2 Eleanor Gouws,3 and Christopher Dye4 
1. South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch, South Africa 
2. The Global Fund to Fight AIDS, Tuberculosis and Malaria, and Department of Public Health, Erasmus MC, University 
Medical Centre Rotterdam, Rotterdam, The Netherlands  
3. Policy, Evidence and Partnerships Department, Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland 
4. World Health Organization, Geneva, Switzerland 
 
Correspondence to: Brian Williams at williamsbg@me.com. 
 
Abstract 
In people infected with HIV the RNA viral load is a good 
predictor of the rate of loss of CD4 cells at a population 
level but there is still great variability in the rate of decline 
of CD4 cells among individuals. Here we show that the 
pre-infection distribution of CD4 cell counts and the 
distribution of survival times together account for 87% of 
the variability in the observed rate of decline of CD4 cells 
among individuals. The challenge is to understand the 
variation in CD4 levels, among populations and 
individuals, and to establish the determinants of survival of 
which viral load may be the most important. 
Introduction 
A recent study by Rodríguez et al. [1], using data from 
three cohorts of HIV-positive people in the United States 
of America, showed that RNA viral load in patients 
presenting with HIV infection is positively correlated with 
the rate of loss of CD4 T-cells at a population level (n = 
1289, p < 0.0001; our estimate), confirming the earlier 
results of Mellors et al. [2]. However, the RNA viral load 
only explained 4% (2% to 6%, 95% confidence limits,) of 
the variability in the rate at which CD4 T-cells declined 
among individual people. Rodríguez et al. [1] asked what 
other factors are likely to drive the decline in CD4 T-cells 
and account for the remaining 96% of the variability and 
noted the implications of these findings for treatment 
decisions and for understanding the pathogenesis of HIV. 
In subsequent letters Gottlieb et al. [3] and Lima et al. [4] 
responded that the paper by Rodríguez et al. [1] challenges 
the utility of using early viral load measurements to predict 
disease outcome in individuals and the rate at which CD4 
cells are lost and suggested the use of more sophisticated 
techniques for the analysis of the data. 
 We have recently published an epidemiological model 
of CD4 cell count decline among populations of HIV-
infected adults in Zambia and South Africa [5]. Our model 
takes as input, for a particular population, the frequency 
distribution of CD4 T-cell counts among HIV-negative 
adults and the distribution of survival times after HIV-
infection. We assume that there is a 25% decline in CD4 
cell counts in the few weeks immediately following 
infection [6-8] and that the distribution of survival times 
after HIV-infection is independent of the initial CD4 cell 
count. Using this model we were able to predict the 
distribution of CD4 counts in the corresponding HIV-
positive population with no free parameters apart from the 
normalization to match the size of the sample. Applied to 
data from South African and Zambian populations, the 
model explained 82% and 76%, respectively, of the 
variability in the distribution of CD4 cell counts among 
HIV-infected adults; the remaining variability was entirely 
accounted for by the stochastic sampling errors in the data. 
Here we use our model to predict the distribution of the 
rate of decline of CD4 cell counts in the population studied 
by Rodríguez et al. [1]. 
Methods 
Rodríguez et al. [1] used data from people infected with 
HIV enrolled in the Research in Access to Care for the 
Homeless Cohort (REACH), the San Francisco Men’s 
Health Study (SFMHS) cohort and the Multicenter AIDS 
Cohort Study (MACS) cohort. Because they did not 
present data on the distribution of CD4 cell counts among 
the corresponding HIV-negative populations we used the 
distribution among patients in their study in the lowest 
category of presenting RNA (less than 0.5/μL, median 
0.084/μL), who also have the highest CD4 cell counts 
(median 654/μL, inter-quartile range 474−864/μL). We 
assume that the distribution of CD4 cell counts in this 
group of patients represents the distribution in HIV-
infected adults immediately after the initial decline in the 
few weeks following infection. A log-normal curve gave a 
good fit to the distribution of CD4 cell counts for HIV-
negative adults in the South African and Zambian 
populations [5] and we fitted a log-normal curve to the 
median and inter-quartile range of CD4 counts given by 
Rodríguez et al. [1]. Based on data from the CASCADE 
study [9], we use a Weibull function with a mean of ten 
years and a shape parameter of 2.25 [5] for the distribution 
of survival after HIV infection. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The distribution of the rate of decline of CD4 T-cells in HIV-
infected adults as reported by Rodríguez et al. [1]. Dots and error bars are 
the data summed over the whole sample; the line is the distribution 
predicted using the model described in the text [5]. The vertical axis gives 
the number of people with HIV in each category of CD4 decline 
(/10μL/year). 
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Results 
The distribution of the rate at which CD4 cell counts 
decline as predicted by  our model is compared to the  data 
published by Rodríguez and et al. [1], summed over all the 
participants in their study, in Figure 1. There is good 
agreement between the predicted and observed  
distributions of the rate at which CD4 cell counts decline 
(Figure 1) apart from a small number of people whose 
viral load was either falling slowly or increasing (points 
close to zero or the left of the vertical axis in Figure 1.) 
The model accounts for 87% of the variability in the data.  
Conclusions 
The predicted distribution depends on the variability in the 
initial, pre-infection CD4 cell counts and the variability in 
the survival after infection with HIV. The question to be 
asked is: what determines each of these? CD4 cell counts 
vary widely among HIV-negative adults in association 
with a range of genetic, biological and physiological 
effects including smoking, physical exercise, and chronic 
infections [10]. In individual people significant 
fluctuations may be recorded between readings taken only 
a few weeks apart, due to diurnal rhythms, acute 
infections, stress, exercise or the reproducibility of test 
results [10]. Any additional random variation, over and 
above that explained by the model, would further broaden 
the measured distribution and could account for the slow 
rates of decline, and even increases, in CD4 cell counts 
observed in a few of the patients as shown in Figure 1. The 
distribution of survival after HIV infection and without 
ART is well characterized and varies most obviously with 
the age at infection [9] and with viral load [2] although the 
detailed mechanisms are not well understood. 
 Rodríguez et al. [1] challenge the scientific community 
to explain the substantial variation in the observed rates at 
which CD4 cell counts decline in people infected with 
HIV. While RNA viral load only explains 4% of the 
variability in the rates at which individual CD4 cell counts 
decline, our model shows that most of the variability in the 
rate at which CD4 cell counts decline can be explained by 
the distribution of the pre-infection CD4 cell counts and 
the distribution of survival after infection. The reality must 
be considerably more complex than suggested by our 
simple model where we take the distribution of survival 
times as given leaving the relationship between viral load 
and survival an open question. If it were the case that 
individual RNA viral load completely determines the 
individual survival, so that the distribution of the former 
completely determines the distribution of the latter, the 
variation arising from the variability in initial CD4 cell 
counts would remain and the model would be consistent 
with the claim by Mellors et al. [2] While our analysis 
does not fully answer the questions raised in the paper by 
Rodríguez et al. [1] or in the ensuing correspondence [3, 4] 
we believe that it helps to focus the questions. 
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